» Articles » PMID: 19514070

Normal Ovarian Function and Assessment of Ovarian Reserve in the Survivor of Childhood Cancer

Overview
Date 2009 Jun 11
PMID 19514070
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

Increasingly young people survive cancer in childhood and as a result complications of its treatment are becoming more common and important. Premature ovarian failure is recognized as a complication of radiotherapy to a field that includes the pelvis and alkylating-agent-based chemotherapy. Young pre-pubertal girls are not protected from the effects of gonadal toxic therapy. A young woman, successfully treated for cancer during childhood, may experience regular periods in the presence of a significantly reduced ovarian reserve. There is, however, no reliable measure of ovarian reserve available for the individual woman. Assessment of ovarian function relies on the use of surrogate markers such as follicle stimulating hormone, inhibin-B, and anti-mullerian hormone as well as ultrasound assessment of ovarian volume and antral follicle count. We discuss the physiology of normal ovarian function, the effects of cancer treatments on ovarian function and the techniques for evaluation of ovarian reserve in survivors of childhood cancer.

Citing Articles

Development and validation of age-specific risk prediction models for primary ovarian insufficiency in long-term survivors of childhood cancer: a report from the Childhood Cancer Survivor Study and St Jude Lifetime Cohort.

Im C, Lu Z, Mostoufi-Moab S, Delaney A, Yu L, Baedke J Lancet Oncol. 2023; 24(12):1434-1442.

PMID: 37972608 PMC: 10842148. DOI: 10.1016/S1470-2045(23)00510-7.


FOXO3 and PTEN expression in the ovary of girls with extra-gonadal cancer with or without chemotherapy treatment prior to cryopreservation.

Albamonte M, Calabro L, Albamonte M, Vitullo A BMC Womens Health. 2023; 23(1):509.

PMID: 37737182 PMC: 10515424. DOI: 10.1186/s12905-023-02648-x.


Fertility status in childhood cancer survivors of hematological malignancies: a systematic review.

Karalexi M, Kontogeorgi A, Papaioannou G, Neofytou S, Messaropoulos P, Moschovi M Hormones (Athens). 2023; 22(2):211-221.

PMID: 36964890 DOI: 10.1007/s42000-023-00443-9.


Fertility after Curative Therapy for Sickle Cell Disease: A Comprehensive Review to Guide Care.

Nickel R, Maher J, Hsieh M, Davis M, Hsieh M, Pecker L J Clin Med. 2022; 11(9).

PMID: 35566443 PMC: 9105328. DOI: 10.3390/jcm11092318.


Structural diversity of p63 and p73 isoforms.

Osterburg C, Dotsch V Cell Death Differ. 2022; 29(5):921-937.

PMID: 35314772 PMC: 9091270. DOI: 10.1038/s41418-022-00975-4.